|
1-(3-chloro-5-{[4-(4-chloro-2-thienyl)-5-(4-cyclohexylpiperazin-l-yl)-1,3-thiazol-2-yl]carbamoyl}- 2-pyridyl) piperidine-4-caboxylic acid Monomaleate |
|---|---|
| Trade Name | |
| Orphan Indication | Idiopathic thrombocytopenic purpura |
| USA Market Approval | USA |
| USA Designation Date | 2011-09-01 00:00:00 |
| Sponsor | Dova Pharmaceuticals, Inc.;240 Leigh Farm Road, Suite 245;Durham, North Carolina, 27707 |
